METHOD OF TREATING ENTEROVIRUS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS

The present disclosure describes a method of treating a respiratory enterovirus infection in a human subject with COPD which includes administering to the subject a therapeutically effective amount of vapendavir or a pharmaceutically acceptable salt thereof, thereby treating the respiratory enterovi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SQUIRES, Katherine Elizabeth, LAESSIG, Katie, KELLY, Andrea True, CLERICI, John Michael, GIROIR, Brett Paul, RUDNICK, Seth Allen
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure describes a method of treating a respiratory enterovirus infection in a human subject with COPD which includes administering to the subject a therapeutically effective amount of vapendavir or a pharmaceutically acceptable salt thereof, thereby treating the respiratory enterovirus infection in the subject. Pharmaceutical formulations of vapendavir are also disclosed. La présente divulgation concerne une méthode de traitement d'une infection à entérovirus respiratoire chez un sujet humain atteint de BPCO qui comprend l'administration au sujet d'une quantité thérapeutiquement efficace de vapendavir ou d'un sel pharmaceutiquement acceptable de celui-ci, ce qui permet de traiter l'infection à entérovirus respiratoire chez le sujet. La divulgation concerne également des formulations pharmaceutiques de vapendavir.